Option chain shows key data for Geovax Labs's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Geovax Labs.

Geovax Labs (NASDAQ:GOVX) Stock, Option Chain

Geovax Labs

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Wall,Street,And,New,Street.,New,York.,Usa.,06-30-2012

Earnings

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

APLD

GOVX

MURA

RZLV

SKYE

SPRB

Crude Oil Moves Lower; Citigroup Posts Upbeat Results

Nvidia, Meta Platforms, Oracle, Palantir, And Tesla: 5 Trending Stocks Amid Monday's Market Meltdown

Equities

BULL

SNYR

Nasdaq Surges 100 Points; Bank of America Earnings Top Views

The,New,York,Stock,Exchange,Is,An,American,Stock,Exchange

Analyst Color

Government

Economics

Federal Reserve

General

AAPL

ARBB

ERIC

DELLL

U.S. stock futures were volatile on Tuesday following a two-day advance. Futures of major benchmark indices were mixed in premarket.

US Stock Futures Waver After Two-Day Rally: Trump&#39;s Tariff Moves Could End A 3-Year &#39;Rolling Recession,&#39; Says Expert

Geovax Labs Inc

Press Releases

GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity Conference

GeoVax Receives Notice of Allowance For Cancer Vaccine Patent

Presenting on the Emerging Growth Conference 78 Day 1 on January 15 Register Now

Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now

Presenting on the Emerging Growth Conference 79 Day 1 on February 18 Register Now

Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now

Presenting on the Emerging Growth Conference 80, Day 1 on March 26 - Register Now

Presenting on the Emerging Growth Conference 80 Day 2 on March 27 Register Now

Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream

Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream

AEMD

ANPCY

ASBP

ASPI

ATCH

ATWT

BDRX

BENF

BIXT

BNRG

BNZI

BOSC

BVAXF

CBIH

CLNN

CSE:BIOV

CSE:HG

CSE:PMC

CSE:RUA

CUAUF

CYIO

EGYF

ELRRF

EVFM

GOSS

GOVXW

HDRSF

HGRAF

IMRN

IPWR

JAGX

LGVN

MESO

MKTW

MNMRF

NCSM

NZAUF

OMEX

OPWEF

PBEGF

PLAB

PMCCF

PSQH

RGBP

SEVCF

SIGY

SKYH

TSX:CNL

TSX:ELO

TSX:TXP

TSX:URE

TSX:VGZ

TSXV:CCCM

TSXV:HI

TSXV:MNRG

TSXV:OPW

TSXV:RUA

TSXV:UCU

TSXV:WRLG

TSXV:XBOT

UCAR

USEG

UURAF

VANI

VIOT

WRLGF

XBOTF

XXII

ABVC BioPharma

BioLineRx Ltd. - American Depositary Shares

BioLine Rx

Bolt Biotherapeutics, Inc. - Common Stock

Bolt Biotherapeutics

BioRestorative Therapies, Inc. - Common Stock

BioRestorative Therapies

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biofarma

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Dogwood Therapeutics, Inc. - Common Stock

Dogwood Therapeutics

Ernexa Therapeutics

HOOKIPA Pharma

Imunon

IN8bio

Intensity Therapeutics, Inc. - Common Stock

Intensity Therapeutics

Kairos Pharma

Moleculin Biotech

MEI Pharma

Marker Therapeutics

Minerva Neurosciences, Inc - Common Stock

Minerva Neurosciences

NextCure

BiomX

Phio Pharmaceuticals Corp. - Common Stock

Phio Pharma

Polyrizon

Portage Biotech

Rallybio

SAB Biotherapeutics

Synlogic

HC Wainwright & Co.

D. Boral Capital

Alliance Global Partners

EF Hutton

Noble Capital Markets

Comments

Geovax Labs

Geovax Labs (GOVX) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell